🔥 We have been featured on Shark Tank India.Episode 13

🔥 We have been featured on Shark Tank India

logologo
Search or Ask Iris
Ctrl+K
gift
arrow
WhatsApp Icon

Navin Fluorine Q3 Profit Soars 122%, Share Price Hits High

NAVINFLUOR

Navin Fluorine International Ltd

NAVINFLUOR

Ask AI

Ask AI

Introduction

Navin Fluorine International Ltd. announced exceptional financial results for the third quarter of fiscal year 2026, ending December 31, 2025. The specialty chemicals company reported a remarkable 122% year-on-year (YoY) increase in its consolidated net profit, which spurred a significant rally in its share price, pushing it to an all-time high. This performance underscores the company's robust operational efficiency and strong demand across its key business verticals.

A Stellar Quarterly Performance

The company's net profit for Q3 FY26 surged to ₹185.40 crore, a substantial increase from the ₹83.60 crore recorded in the corresponding quarter of the previous fiscal year. This growth was driven by a strong top-line performance, with net revenue from operations rising by 47% YoY to ₹892.37 crore from ₹606.20 crore.

Operational efficiency was a key highlight of the quarter. Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) grew by an impressive 109% to ₹307.57 crore, compared to ₹147.31 crore in Q3 FY25. Consequently, the operating EBITDA margin saw a significant expansion of 1,017 basis points, climbing to 34.5% from 24.3% in the year-ago period.

MetricQ3 FY26 (₹ Crore)Q3 FY25 (₹ Crore)Year-on-Year Growth
Net Revenue892.37606.2047%
EBITDA307.57147.31109%
Profit After Tax (PAT)185.4083.60122%
EBITDA Margin34.5%24.3%+1017 bps

Segment-Wise Growth Drivers

Growth was broad-based, with all three core business segments delivering strong results. The High Performance Products (HPP) vertical, which includes refrigerants and inorganic fluorides, reported a 35% revenue increase to ₹412 crore, driven by higher volumes and better price realisations in both domestic and international markets.

The Specialty Chemicals segment delivered its best-ever quarterly performance, with revenue climbing 60% to ₹354 crore. The company noted strong order visibility for the fourth quarter and a robust product pipeline.

The Contract Development and Manufacturing Organisation (CDMO) business also maintained its strong momentum, posting a 61% revenue surge to ₹127 crore. The company has successfully commenced commercial supplies under a key European Master Service Agreement (MSA), with a positive outlook for calendar year 2026 and beyond.

Market Reaction and Stock Performance

Investors responded positively to the strong earnings report. Navin Fluorine's shares rallied over 5% following the announcement, hitting a new all-time high. The stock has demonstrated strong performance over the past year, gaining approximately 57%. As of early February 2026, the company's market capitalization stood at around ₹33,840 crore. The stock's 52-week range is between ₹3,566.00 and ₹6,965.00, indicating significant investor confidence.

Strategic Initiatives and Capex Update

Navin Fluorine continues to invest in capacity expansion to support future growth. A significant recent development was the commissioning of its new 40,000 tonnes per annum (TPA) Hydrofluoric Acid (HF) plant at Dahej on February 6, 2026. This backward integration is expected to be margin-accretive.

Other key projects are also progressing as planned. The capex for additional HFC capacity is underway, and the R32 project remains on track for commissioning in Q3 FY27. The Chemours project is expected to be completed in Q1 FY27, while the debottlenecking of the Multi-Purpose Plant (MPP) at Dahej is set for Q3 FY27. These strategic investments are aimed at catering to growing demand and strengthening the company's market position.

Financial Health and Shareholder Returns

Demonstrating its strong financial position, Navin Fluorine has remained debt-free from March 2020 to March 2024. The company also rewarded its shareholders by declaring an interim dividend of ₹6.50 per share for the fiscal year 2026.

Analyst Perspectives and Outlook

Brokerages have largely responded with optimism following the Q3 results, with most raising their target prices. Of the 29 analysts covering the stock, 21 have a 'buy' rating. Jefferies, Nuvama, and UBS have maintained 'buy' ratings, citing strong earnings visibility from contracts and capacity expansion. In contrast, Citi has a 'sell' recommendation, suggesting that the significant upside may already be factored into the current valuation.

BrokerageRatingPrice Target (₹)Key Commentary
JefferiesBuy7,800Strong beat on estimates; visibility on earnings growth over FY27-28.
NuvamaBuy7,653Stellar quarter; growth levers remain solid across all segments.
UBSBuy7,800Robust growth and improved margins; capacity expansion to support growth.
CitiSell5,500Margin expansion noted, but upside appears factored into current valuation.

Conclusion

Navin Fluorine's outstanding performance in the third quarter of FY26 highlights its strong execution capabilities and favorable market positioning. With robust growth across all segments, expanding margins, and strategic capacity expansions underway, the company has laid a solid foundation for sustained growth. While valuations remain a point of discussion among analysts, the company's operational momentum and clear strategic direction provide a positive outlook for the coming years.

Frequently Asked Questions

The company reported a 122% year-on-year increase in net profit to ₹185.4 crore, a 47% rise in revenue to ₹892.37 crore, and a 109% surge in EBITDA to ₹308 crore.
All segments showed strong growth. Specialty Chemicals revenue grew by 60%, High Performance Products (HPP) by 35%, and the Contract Development and Manufacturing Organisation (CDMO) segment by 61%.
Analyst views are largely positive. Brokerages like Jefferies, Nuvama, and UBS have 'buy' ratings with raised target prices, citing strong growth visibility. However, Citi maintains a 'sell' rating due to valuation concerns.
The company recently commissioned a new 40,000 TPA Hydrofluoric Acid plant at Dahej. It is also expanding its HFC capacity and progressing with its R32 and Chemours projects to meet growing demand.
As of early February 2026, Navin Fluorine's market capitalization is approximately ₹33,840 crore, and its Price-to-Earnings (P/E) ratio stands at around 72.3.

A NOTE FROM THE FOUNDER

Hey, I'm Aaditya, founder of Multibagg AI. If you enjoyed reading this article, you've only seen a small part of what's possible with Multibagg AI. Here's what you can do next:

It's all about thinking better as an investor. Welcome to a smarter way of doing stock market research.